Class IITerminatedD-0821-2020
Drug recall · February 5, 2020
Dimercaptopropanesulfonate Sodium recall
Why: Presence of Particulate Matter: Particulates observed in vials release for dispensing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704
- Lots / codes
Lot #18J1081, Exp 03/10/19
- Quantity
- N/A
- Company
- McGuff Compounding Pharmacy Services, Inc., Santa Ana, CA
- Distribution
- Prescriptions filled for patients in the following states: AK, AZ, CA, CO, DC, FL, IN, MA, MT, NC, NJ, NY, OR, SC, TX, UT, VA, WA, and WI.
- Initiated
- February 14, 2019 · Voluntary: Firm initiated
- Classified
- January 29, 2020
- Reported
- February 5, 2020
- Ended
- November 20, 2023
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.